We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

CAR T-cell Therapy: Reprogramming the Immune System To Treat Cancer

Video   Oct 04, 2019 | Taken from TEDx Talks, YouTube

 

At the Malaghan Institute for Biomedical Reserach, researchers are developing third generation CAR-T immunotherapy treatments which aim to be more effective with less side effects than previous therapies.

Using patients own modified T-cells, CAR-T therapy has the ability to vanquish cancer cells, vastly improving outcomes of once life threatening diseases.

This year, 2019, Rob hopes to begin clinical trials for CAR-T therapy in New Zealand through the collaboration of scientists from the Malaghan Institute and international researchers. He is optimistic that this next generation treatment will present a new paradigm for treatment of lymphomas and possibly for other cancers in the future.

Dr Robert Weinkove is Clinical Director of the Malaghan Institute, a biomedical research institute in Wellington, New Zealand. After studying medicine at the University of Cambridge and Kings College London, Rob trained in Hematology in London and Germany before moving to New Zealand in 2008 and gaining a doctorate with the University of Otago.

Rob is a key member of the Cancer Immunotherapy Programme to develop and manufacture ‘chimeric antigen receptor’ (CAR) T-cells for treatment of lymphoma and other blood cancers. He also holds a joint role as a  Hematologist at Wellington Blood & Cancer Centre.

 
More Information
 
 
 

Recommended Videos

Hacking Bacteria To Fight Disease

Video

Explore how synthetic biologists are programming bacteria to fight cancer by manipulating their DNA.

WATCH NOW

How Does Chemotherapy Work?

Video

Discover how chemotherapy drugs use cytotoxic agents to attack cancer cells and the impact they have on your body.

WATCH NOW

Targeting Ion Channels in Drug Discovery

Video

Marc Rogers, Metrion Biosciences, outlines the benefits of targeting ion channels for pain and some of the hurdles in developing successful ion channel modulators.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Cancer Research Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE